Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has authorized the repurchase of $4 billion of shares of its common stock in the open market or in negotiated transactions.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Thursday, November 10, 2022
Information
Tags: 
Health, Medical Devices, Health Technology, Research, Science, Pharmaceutical, Biotechnology, Thermo Fisher Scientific, Science, Mindful Scientific Inc., PPD, Research, Patheon, Laboratory, Health, NYSE, Diversified Pharmaceutical Services, TMO, Invitrogen, Applied Biosystems, Fisher Scientific, Management
Geotags: 
UNITED STATES, NORTH AMERICA, MASSACHUSETTS
⚠ partially generated by AI ↴
Organisation: 
THERMO FISHER SCIENTIFIC, THERMO FISHER SCIENTIFIC INC.
Stock Symbol: 
NYSE:TMO
Summary
Key Points: 
  • Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has authorized the repurchase of $4 billion of shares of its common stock in the open market or in negotiated transactions.
  • Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion.
  • Our Mission is to enable our customers to make the world healthier, cleaner and safer.
  • Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.


Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has authorized the repurchase of $4 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Copyright: 
Copyright Business Wire 2022